The DOI matches its Crossref record; 89 of the 90 references it cites were found in a registry or an index.
Health effects of trans-fatty acids: experimental and observational evidence
Abstract
Background/objectives Growing evidence indicates that trans-fatty acids (TFA) adversely affect cardiovascular health. As part of the World Health Organization (WHO) Scientific Update on TFA, we reviewed the evidence for effects of TFA consumption on coronary heart disease (CHD).Subjects/methods We searched Medline publications examining TFA consumption and CHD risk factors or outcomes, emphasizing results of studies in humans. We evaluated and synthesized evidence from both controlled feeding trials evaluating risk factors and long-term observational studies evaluating risk factors or clinical outcomes, each of which have complementary strengths and limitations, to enable the most robust and reliable inferences of effects.Results The effects of TFA consumption on risk factors most consistently seen in both controlled trials and observational studies included adverse lipid effects (for example [upward arrow] low-density lipoprotein cholesterol, [downward arrow] high-density lipoprotein cholesterol (HDL-C), [upward arrow] total/HDL-C ratio), proinflammatory effects (for example [upward arrow] tumor necrosis factor-alpha activity, [upward arrow] interleukin-6, [upward arrow] C-reactive protein) and endothelial dysfunction. These effects were most prominent in comparison with cis unsaturated fats; adverse effects on total/HDL-C and endothelial function were also seen in comparison with saturated fatty acids (SFA). TFA may also worsen insulin sensitivity, particularly among individuals predisposed to insulin resistance; possible effects on weight gain and diabetes incidence require further confirmation. Five retrospective case-control studies and four prospective cohort studies demonstrated positive associations between TFA consumption and CHD events. A meta-analysis of prospective studies indicated 24, 20, 27 and 32% higher risk of myocardial infarction (MI) or CHD death for every 2% energy of TFA consumption isocalorically replacing carbohydrate, SFA, cis monounsaturated fatty acids and cis polyunsaturated fatty acids, respectively. The differential effects of specific TFA isomers may be important but are less well established. The available evidence indicates that trans-18:1 and particularly trans-18:2 isomers have stronger CHD effects than trans-16:1 isomers. The limited data suggest that the experimental effects of ruminant and industrial TFA are similar when consumed in similar quantities, but very few persons consume such high levels of ruminant TFA, and observational studies do not support adverse CHD effects of ruminant TFA in amounts actually consumed.Conclusions Controlled trials and observational studies provide concordant evidence that consumption of TFA from partially hydrogenated oils adversely affects multiple cardiovascular risk factors and contributes significantly to increased risk of CHD events. The public health implications of ruminant TFA consumption appear much more limited. The effects of specific TFA isomers require further investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Quantitatively, dietary trans fatty acids have a similar raising effect on LDL-C to that of SFAs.64”
From ESC/EAS Guidelines for the management of dyslipidaemias (2011) · cites this paper as [64]
In the citing paper
“While small amounts of “natural” TFA are found in meats and milk of ruminants (e.g., cow, sheep, goat; formed by gut microorganisms), these contribute minimally to diet (<0.5%E) and do not associate with CVD risk;375 indeed, trans-16:1n-7, a trace TFA biomarker of dairy fat, is linked to lower risk of diabetes and sudden death.247”
From Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity: A Comprehensive Review (2016) · cites this paper as [375]
Citations
Cites
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350 · cited 2×
“…relationships between TFA consumption and cancer incidence, and significant associations have generally not been observed (World Cancer Research Fund, 2007), although in the 20-year follow-up of the Nurses' Health Study, TFA intake during the premenopausal years was associated with incidence…”
BackgroundSelf-citationDiet, lifestyle, and the risk of type 2 diabetes mellitus in women.
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., & Willett, W. C. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010492 · Cited by 2,901
Self-citationMensink, R. P., Zock, P. L., Kester, A. D., & Katan, M. B. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/77.5.1146 · Cited by 2,811 · cited 5×
“In one metaanalysis of controlled trials (Mensink et al., 2003), the estimates of TFA effects on serum lipoproteins were based on calculations of changes in 18:1 TFA intake, the predominant isomer in partially hydrogenated vegetable oils.”
BackgroundMethodInfluentialDietary Fat Intake and the Risk of Coronary Heart Disease in Women
Hu, F. B., Stampfer, M. J., Manson, J. E., Rimm, E., Colditz, G. A., Rosner, B. A., Hennekens, C. H., & Willett, W. C. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711203372102 · Cited by 1,782
Self-citationTrans fatty acids and cardiovascular disease
Mozaffarian, D., Katan, M. B., Ascherio, A., Stampfer, M. J., & Willett, W. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054035 · Cited by 1,752 · cited 9×
“…BMI, aspirin use, history of hypertension or hypercholesterolemia, alcohol use, and consumption of dietary SFA, nÀ3 PUFA, nÀ6 PUFA, MUFA, protein, fiber and total energy, the multivariable RR associated with a 2%E increment in TFA intake was 1.26 (95% CI ¼ 0.98–1.60) (Mozaffarian et al., 2006).”
BackgroundMethodInfluentialSelf-citationMensink, R. P., & Katan, M. B. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008163230703 · Cited by 1,424 · cited 3×
“three trials (Mensink and Katan, 1990; Zock and Katan, 1992; Aro et al. 1997), partially hydrogenated high-oleic-acid sunflower oil (not often used in commercially available food products) was the main source of TFA, in which 18:1 n 9 (D9) elaidic acid was the most common TFA isomer.”
BackgroundInfluentialIntake of trans fatty acids and risk of coronary heart disease among women
WILLETT, W. (1993) · The Lancet · doi:10.1016/0140-6736(93)90350-p · Cited by 1,025 · cited 6×
“In the first report on TFA from the Nurses’ Health Study (Willett et al., 1993), when total intake of TFA was partitioned into industrial and ruminant sources, the positive association with CHD risk was entirely explained by industrial TFA.”
BackgroundInfluentialSelf-citationDietary fat intake and risk of type 2 diabetes in women
Salmerón, J., Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G. A., Rimm, E. B., & Willett, W. C. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.6.1019 · Cited by 818 · cited 4×
“overweight or obese or who had lower levels of physical activity (Salmeron et al., 2001).”
BackgroundInfluentialSelf-citationDietary Patterns and Risk for Type 2 Diabetes Mellitus in U.S. Men
van Dam, R. M., Rimm, E. B., Willett, W. C., Stampfer, M. J., & Hu, F. B. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-3-200202050-00008 · Cited by 801 · cited 2×
“As described above, the Iowa Women's Health Study (Meyer et al., 2001) and Health Professionals Follow-up Study (van Dam et al., 2002) detected no significant associations of TFA consumption with incidence of type II diabetes.”
BackgroundInfluentialSelf-citationDietary fat and risk of coronary heart disease in men: cohort follow up study in the United States
Ascherio, A., Rimm, E. B., Giovannucci, E. L., Spiegelman, D., Meir, S., & Willett, W. C. (1996) · BMJ · doi:10.1136/bmj.313.7049.84 · Cited by 739 · cited 2×
“In the first report from this study (Ascherio et al., 1996), 734 acute MI or CHD deaths were documented during 6 years of follow-up among Health effects of trans-fatty acids D Mozaffarian et al S13 European Journal of Clinical Nutrition 43 757 health professionals aged 40–75 years and free of…”
BackgroundSelf-citation
Research works printed but not linked: 2
- European Food Safety Authority (2004). Opinion of the scientific panel on dietetic products, nutrition and allergies on a request from the Commission related to the presence of trans fatty acids in foods and the effect on human health of the consumption of trans fatty acids. EFSA J 81, 1–49.
- Hu FB, Manson JE, Stampfer MJ, Colditz G, Liu S, Solomon CG et al. (2001b). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345, 790–797. · DOI · Paper page
Cited by
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz455 · Cited by 8,961
Heart Disease and Stroke Statistics—2013 Update: A Report From the American Heart Association
Go, A. S., Mozaffarian, D., Roger, V. L., Benjamin, E. J., Berry, J. D., Borden, W. B., Bravata, D. M., Dai, S., Ford, E. S., Fox, C. S., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828124ad · Cited by 5,292
Self-citationChronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Mach, F., Baigent, C., Catapano, A. L., Koskinas, K. C., Casula, M., Badimon, L., Chapman, M. J., De Backer, G. G., Delgado, V., Ference, B. A., et al. (2019) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2019.08.014 · Cited by 4,854
ESC/EAS Guidelines for the management of dyslipidaemias
Reiner, Ž., Catapano, A. L., De Backer, G., Graham, I., Taskinen, M.-R., Wiklund, O., Agewall, S., Alegria, E., Chapman, M. J., Durrington, P., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr158 · Cited by 3,549
Metadata
- Authors
- Mozaffarian, D., Aro, A., & Willett, W. C.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Mozaffarian, D
- Venue
- European Journal of Clinical Nutrition
- Published
- 2009-05
- Volume
- 63
- Issue
- S2
- Pages
- S5-S21
- ISSN
- 0954-3007 (ISSN-L)
- 1476-5640
- OpenAlex
- W2118109560
- Cited by
- 662
- References
- 90
- Citations by year
- 2026: 9 · 2025: 24 · 2024: 27 · 2023: 40 · 2022: 32 · 2021: 37 · 2020: 40 · 2019: 48 · 2018: 29 · 2017: 46 · 2016: 51 · 2015: 58 · 2014: 45 · 2013: 42 · 2012: 50
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- European Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
- Funders
- National Institutes of Health (1k08hl075628-01)
- National Heart, Lung, and Blood Institute (K08-HL-075628)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- trans fatty acids, coronary artery disease, cardiovascular risk, LDL cholesterol, HDL cholesterol, inflammation, endothelial dysfunction, insulin sensitivity, insulin resistance, myocardial infarction, ruminant trans fatty acids, industrial trans fatty acids, dietary fat, dietary cholesterol, dietary fiber, dietary sodium, dietary calcium, dietary magnesium, potassium intake
- MeSH terms
- Animals, Coronary Disease, Dietary Fats, Endothelium, Vascular, Humans, Inflammation, Insulin Resistance, Isomerism, Myocardial Infarction, Risk Factors, Trans Fatty Acids, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Health effects of trans-fatty acids: experimental and observational evidence. https://app.cochat.ai/papers/10.1038/sj.ejcn.1602973
- The paper
- Mozaffarian, D., Aro, A., & Willett, W. C. (2009). Health effects of trans-fatty acids: experimental and observational evidence. European Journal of Clinical Nutrition. https://doi.org/10.1038/sj.ejcn.1602973
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.